Work

ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial.

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PubMed

Authors: Min Jeong Kim, Dimitrios Tsinalis, Stefan Franz, Isabelle Binet, Lorenz Gürke, Michael J Mihatsch, Jürg Steiger, Gilbert Thiel, Michael Dickenmann

Institution: University Hospital of Basel

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2993788865

FWCI: 0.758

Cites: 1

Cited by: 12

Related to: 10